Metallothionein expression in colorectal cancer: Relevance of different isoforms for tumor progression and patient survival
Author(s)
Arriaga, Juan MartínLevy, Estrella Mariel
Bravo, Alicia Inés
Bayo, Sergio Morales
Amat, Mora
Aris, Mariana
Hannois, Adrián
Bruno, Luisina Inés
Roberti, Maria Paula
Sánchez Loria, Fernando
Pairola, Alejandro
Huertas, Eduardo
Mordoh, Jose
Bianchini, Michele
Keywords
BIOMARKERCOLORECTAL CANCER
HYPERMETHYLATION
METALLOTHIONEINS
ONCOGENESIS
SURVIVAL
Otras Ciencias Biológicas
Ciencias Biológicas
CIENCIAS NATURALES Y EXACTAS
Full record
Show full item recordOnline Access
http://hdl.handle.net/11336/59258Abstract
Metallothioneins are a family of small, cysteine-rich proteins with many functions. Immunohistochemical evaluation of all metallothionein 1 + 2 isoforms in colorectal tumors has demonstrated an important down-regulation compared with normal tissue, although its prognostic significance is unclear. Moreover, the contribution of individual isoforms to overall metallothionein down-regulation is not known. To address these important issues, we analyzed the messenger RNA expression levels of all functional metallothionein 1 + 2 isoforms by quantitative reverse transcription polymerase chain reaction in 22 pairs of normal and tumor-microdissected epithelia and correlated these to the overall immunohistochemical protein expression. Our results showed that 5 isoforms (MT1G, 1E, 1F, 1H, and 1M) were lost during the transition from normal mucosa to tumor, whereas MT1X and MT2A were less down-regulated, and their expression was correlated with overall protein positivity. Second, we showed that MT1G hypermethylation occurred in cell lines and in 29% of tumor samples, whereas histone deacetylase inhibitors are able to induce most isoforms. Furthermore, we analyzed by immunohistochemistry 107 normal mucosae, 25 adenomas, 81 carcinomas, and 19 lymph node metastases to evaluate metallothionein expression during different stages of cancer development and to assess its relationship to patient survival. A lower immunohistochemical expression was associated with poorer survival, although it was not an independent predictor. Overall, this study identifies for the first time the relevant metallothionein isoforms for colorectal cancer progression, supports the concept that their loss is associated with worse prognosis, and suggests 2 mechanisms for epigenetic repression of metallothionein expression in colorectal tumors.Fil: Arriaga, Juan Martín. Fundación Cáncer. Centro de Investigaciones Oncológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Levy, Estrella Mariel. Fundación Cáncer. Centro de Investigaciones Oncológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Bravo, Alicia Inés. Provincia de Buenos Aires. Ministerio de Salud. Hospital Interzonal de Agudos "Eva Perón"; Argentina
Fil: Bayo, Sergio Morales. Municipio de Vicente López. Hospital Municipal "Prof. Dr Houssay"; Argentina
Fil: Amat, Mora. Instituto Médico Especializado "Alexander Fleming"; Argentina
Fil: Aris, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: Hannois, Adrián. Provincia de Buenos Aires. Ministerio de Salud. Hospital Interzonal de Agudos "Eva Perón"; Argentina
Fil: Bruno, Luisina Inés. Instituto Médico Especializado "Alexander Fleming"; Argentina
Fil: Roberti, Maria Paula. Fundación Cáncer. Centro de Investigaciones Oncológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Sánchez Loria, Fernando. Instituto Médico Especializado "Alexander Fleming"; Argentina
Fil: Pairola, Alejandro. Instituto Médico Especializado "Alexander Fleming"; Argentina
Fil: Huertas, Eduardo. Instituto Médico Especializado "Alexander Fleming"; Argentina
Fil: Mordoh, Jose. Instituto Médico Especializado "Alexander Fleming"; Argentina. Fundación Cáncer. Centro de Investigaciones Oncológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: Bianchini, Michele. Fundación Cáncer. Centro de Investigaciones Oncológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Date
2018-09-12Type
info:eu-repo/semantics/articleIdentifier
oai:ri.conicet.gov.ar:11336/59258Arriaga, Juan Martín; Levy, Estrella Mariel; Bravo, Alicia Inés; Bayo, Sergio Morales; Amat, Mora; et al.; Metallothionein expression in colorectal cancer: Relevance of different isoforms for tumor progression and patient survival; W B Saunders Co-Elsevier Inc; Human Pathology; 43; 2; 2-2012; 197-208
0046-8177
http://hdl.handle.net/11336/59258
CONICET Digital
CONICET